Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05567744 · ClinicalTrials.gov registry record
Registry for CADASIL
A clinical trial of Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT05567744: Recruiting study of Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy, sponsored by University of Wisconsin, Madison.
NCT05567744 is a study of Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 2,500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05567744, a study of Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL or are at risk. Participation means that your name will be added to a list of people who will be invited to participate in future research studies on CADASIL. Participants must be 18 years or older, and will remain on the registry until they request to be removed.
Primary Outcome
Create a list of persons willing to volunteer for CADASIL-related research to facilitate efficient recruitment.
Conditions Studied
Interventions
- OTHER Registry
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2022-06-03 |
| Est. Completion | 2027-10 |
What NCT05567744 shows while recruiting
NCT05567744 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy appearing as the primary indexed condition, and to 1 intervention - of which Registry is the first listed.
NCT05567744 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05567744 about?
NCT05567744 is a clinical study titled "Registry for CADASIL". This study is being done in order to create a registry (list) of people interested in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) research. It may be that you have a family member or other loved one with CADASIL, or that you may have CADASIL o...
What is the current status of trial NCT05567744?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2022-06-03. Estimated completion is 2027-10.
What conditions does trial NCT05567744 study?
This clinical trial studies the following conditions: Cerebral Autosomal Dominant Ateriopathy With Subcortical Infarcts and Leukoencephalopathy.
What interventions are being tested in trial NCT05567744?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT05567744?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05567744 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI